A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists. Subasinghe NL, Lanter J, Markotan T, Opas E, McKenney S, Crysler C, Hou C, O'Neill J, Johnson D, Sui Z Bioorg Med Chem Lett. 2012 Dec 20. PMID: 23294701. Abstract CommentRecommendBookmarkWatch